Company profile: BioAge Labs
1.1 - Company Overview
Company description
- Provider of clinical-stage therapeutics for obesity, metabolic, and neurodegenerative diseases. Offers Azelaprag, an oral APJ agonist to enhance weight loss and improve body composition alongside incretin drugs; BGE-100, a CNS-penetrant NLRP3 inhibitor targeting neuroinflammation; and a discovery platform analyzing multi-omics to identify aging and disease mediators and new drug targets.
Products and services
- Azelaprag: An oral APJ agonist for obesity that enhances weight loss and improves body composition when used with incretin drugs
- BGE-100: A CNS-penetrant NLRP3 inhibitor targeting neuroinflammation, intended to address neurodegenerative conditions by correcting chronic inflammasome activation
- Discovery Platform: A multi-omics analysis platform that identifies molecular mediators of aging and disease to discover new drug targets
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioAge Labs
Xaira
HQ: United States
Website
- Description: Provider of AI-driven drug discovery and therapeutic product development across multiple modalities. Offers R&D of AI methods for biological discovery, molecule and protein design, and clinical development, powered by a data platform that generates, integrates, and learns from multidimensional datasets to advance disease understanding and create medicines targeting resistant molecular targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xaira company profile →
N-SIDE
HQ: Belgium
Website
- Description: Provider of deeptech software and algorithms for life sciences and energy to improve decisions and optimize critical resources. Combines industry expertise with applied mathematics and AI. Products include Lighthouse, software for managing clinical trial supply chains to reduce waste, and a Power Matching Algorithm that optimizes supply and demand to determine day-ahead electricity prices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full N-SIDE company profile →
Tetramer Shop
HQ: Denmark
Website
- Description: Provider of MHC tetramer drug technology for the testing and monitoring of antigen-specific T cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tetramer Shop company profile →
Topaz Technologies
HQ: United States
Website
- Description: Provider of integrated enterprise software solutions and services to the medical research community, delivering animal and clinical research software solutions for complex regulatory environments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Topaz Technologies company profile →
TrialNetworks
HQ: United States
Website
- Description: Provider of a clinical trial optimization system that transforms clinical operations for sponsors and CROs, simplifying site processes through technology. Offers solutions that enable sponsors, CROs and investigators to collaborate, improve quality, shorten timelines, reduce costs, and access the largest global network of active investigators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TrialNetworks company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioAge Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioAge Labs
2.2 - Growth funds investing in similar companies to BioAge Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioAge Labs
4.2 - Public trading comparable groups for BioAge Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →